Array-based evolution of DNA aptamers allows modelling of an explicit sequence-fitness landscape (scientific article)

Q41861993	A 'rule of 0.5' for the metabolite-likeness of approved pharmaceutical drugs
Q38352043	Analysis of a complete DNA-protein affinity landscape
Q41959283	Analysis of drug-endogenous human metabolite similarities in terms of their maximum common substructures
Q47174949	Aptamer Bioinformatics
Q28083114	Aptamer Microarrays-Current Status and Future Prospects
Q38835851	Bioinformatics for the synthetic biology of natural products: integrating across the Design-Build-Test cycle
Q26864314	DNA Aptamers in the Diagnosis and Treatment of Human Diseases
Q28251171	Efficient discovery of anti-inflammatory small-molecule combinations using evolutionary computing
Q42365796	Evolutionary algorithms and synthetic biology for directed evolution: commentary on "on the mapping of genotype to phenotype in evolutionary algorithms" by Peter A. Whigham, Grant Dick, and James Maclaurin
Q28710543	Exploiting genomic knowledge in optimising molecular breeding programmes: algorithms from evolutionary computing
Q92319719	GeneORator: An Effective Strategy for Navigating Protein Sequence Space More Efficiently through Boolean OR-Type DNA Libraries
Q33451579	In silico selection of RNA aptamers
Q37883000	Locked and unlocked nucleosides in functional nucleic acids.
Q26752642	Methods for Improving Aptamer Binding Affinity
Q41445226	Monotonicity of fitness landscapes and mutation rate control.
Q34459376	New Technologies Provide Quantum Changes in the Scale, Speed, and Success of SELEX Methods and Aptamer Characterization
Q26775102	Oligonucleotide Functionalised Microbeads: Indispensable Tools for High-Throughput Aptamer Selection
Q35948439	Overview of electrochemical DNA biosensors: new approaches to detect the expression of life
Q21145317	Predictability of evolutionary trajectories in fitness landscapes
Q41859688	Puf3p induces translational repression of genes linked to oxidative stress
Q35077513	Quantifying the similarity of monotonic trajectories in rough and smooth fitness landscapes
Q38858964	Recommendations on the Implementation of Genetic Algorithms for the Directed Evolution of Enzymes for Industrial Purposes
Q34504896	Replaying the tape of life: quantification of the predictability of evolution
Q42135811	Scientific discovery as a combinatorial optimisation problem: how best to navigate the landscape of possible experiments?
Q38287717	Screening of specific nucleic acid aptamers binding tumor markers in the serum of the lung cancer patients and identification of their activities
Q59142935	Selective Phenome Growth Adapted NK Model: A Novel Landscape to Represent Aptamer Ligand Binding
Q55287229	Simple Methods and Rational Design for Enhancing Aptamer Sensitivity and Specificity.
Q38312729	Simultaneous improvement of specificity and affinity of aptamers against Streptococcus mutans by in silico maturation for biosensor development.
Q35657036	Single-Round Patterned DNA Library Microarray Aptamer Lead Identification
Q36145664	SpeedyGenes: Exploiting an Improved Gene Synthesis Method for the Efficient Production of Synthetic Protein Libraries for Directed Evolution
Q38287400	Synthetic biology for the directed evolution of protein biocatalysts: navigating sequence space intelligently
Q40262879	The apparent permeabilities of Caco-2 cells to marketed drugs: magnitude, and independence from both biophysical properties and endogenite similarities
Q91558906	The role and robustness of the Gini coefficient as an unbiased tool for the selection of Gini genes for normalising expression profiling data
Q30369734	The virtue of innovation: innovation through the lenses of biological evolution
Q24289511	Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson’s, Huntington’s, Alzheimer’s, prions, bactericides, chemical toxicology and others as examples
Q38915342	Tunable resistive pulse sensing: potential applications in nanomedicine
Q40605856	Understanding the foundations of the structural similarities between marketed drugs and endogenous human metabolites
Q92219708	Updates on Aptamer Research